Prelude Therapeutics Inc - FORM S-1 - EX-21.1 - September 4, 2020

Attached files

file filename
EX-23.1 - EX-23.1 - Prelude Therapeutics Incd935180dex231.htm
EX-10.8 - EX-10.8 - Prelude Therapeutics Incd935180dex108.htm
EX-10.7 - EX-10.7 - Prelude Therapeutics Incd935180dex107.htm
EX-10.6 - EX-10.6 - Prelude Therapeutics Incd935180dex106.htm
EX-10.5 - EX-10.5 - Prelude Therapeutics Incd935180dex105.htm
EX-10.2 - EX-10.2 - Prelude Therapeutics Incd935180dex102.htm
EX-10.1 - EX-10.1 - Prelude Therapeutics Incd935180dex101.htm
EX-4.2 - EX-4.2 - Prelude Therapeutics Incd935180dex42.htm
EX-3.3 - EX-3.3 - Prelude Therapeutics Incd935180dex33.htm
EX-3.1 - EX-3.1 - Prelude Therapeutics Incd935180dex31.htm
S-1 - S-1 - Prelude Therapeutics Incd935180ds1.htm
EX-21.1 11 d935180dex211.htm EX-21.1 EX-21.1

Exhibit 21.1

LIST OF SUBSIDIARIES

As of the date of this Registration Statement on Form S-1, Prelude Therapeutics Incorporated has no subsidiaries.

Prelude Therapeutics Inc Reports